European Medicines Agency Grants Orphan Drug Designation to Annamycin in AML
The European Medicines Agency has granted orphan drug designation to annamycin for the treatment of patients with acute myeloid leukemia.
The European Medicines Agency has granted orphan drug designation to annamycin for the treatment of patients with acute myeloid leukemia.
Get the latest on mammogram guidelines from Dr. Ethan Cohen at MD Anderson Cancer Center, as he breaks down the updates and shares his expert…
AHNS Annual Meeting at Combined Otolaryngology Spring Meetings (COSM) 2024 Join all 9 Societies in Chicago, IL! REGISTRATION IS NOW OPEN! Register for the AHNS…
Fred Hutch providers weigh in on new guidelines just issued by the U.S. Preventive Services Task Force that recommend breast cancer screening start at age…
Oncologists present the clinical scenario of a 65-year-old woman with recurrent HR-positive, HER2-low breast cancer, and discuss optimal sequencing of systemic therapies in this setting.
Cervical cancer screening exams like the Pap test and screening for the human papillomavirus (HPV) help find cervical cancer early stage. When found early, the…
The combination of pembrolizumab, trastuzumab, and chemotherapy showed significant improvement in overall survival vs placebo in patients with HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma.
Lyudmila A. Bazhenova, MD, and D. Ross Camidge, MD, PhD, review the DESTINY-Lung01 and DESTINY-Lung02 trials, and the panel provides its impressions of the data.
Donation made 17 years ago changed the future of cancer research at Moffitt
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
By continuing to browse this site you permit us and our partners to place identification cookies on you r browser and agree to our use…